Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD)

2019 ◽  
Vol 10 (4) ◽  
pp. 2148-2160 ◽  
Author(s):  
L. I. Elvira-Torales ◽  
M. J. Periago ◽  
R. González-Barrio ◽  
N. Hidalgo ◽  
I. Navarro-González ◽  
...  

In rats with hepatic steatosis, spinach intake increased gut Lactobacillus and lowered cholesterol and glucose.

Foods ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 1719
Author(s):  
Valentina Castillo ◽  
Fernanda Figueroa ◽  
Karoll González-Pizarro ◽  
Paz Jopia ◽  
Claudia Ibacache-Quiroga

Non-alcoholic fatty liver disease (NAFLD) is a chronic non-communicable disease, with a prevalence of 25% worldwide. This pathology is a multifactorial illness, and is associated with different risks factors, including hypertension, hyperglycemia, dyslipidemia, and obesity. Beside these predisposing features, NAFLD has been related to changes in the microbiota, which favor the disease progression. In this context, the modulation of the gut microbiota has emerged as a new therapeutic target for the prophylaxis and treatment of NAFLD. This review describes the changes in the gut microbiota associated with NAFLD and the effect of probiotics, prebiotics, and synbiotics on the gut microbiota, liver damage, anthropometric parameters, blood lipids, inflammation markers and insulin resistance in these patients.


Author(s):  
Ludovico Abenavoli ◽  
Anna C. Procopio ◽  
Emidio Scarpellini ◽  
Natale Polimeni ◽  
Isabella Aquila ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document